A Complete Blood Count (CBC), often referred to as a Complete Hemogram Test, is a foundational diagnostic blood panel that evaluates overall health. It measures essential blood components, including red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets, alongside differential counts and cell indices. This comprehensive profile helps physicians detect a wide range of conditions, such as anemia, active infections, inflammation, clotting disorders, and nutritional deficiencies. By providing a detailed snapshot of cellular health, the CBC Complete Hemogram serves as a routine screening tool and a vital step in monitoring existing medical conditions.

A Complete Blood Count (CBC), often referred to as a Complete Hemogram Test, is a foundational diagnostic blood panel that evaluates overall health. It measures essential blood components, including red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets, alongside differential counts and cell indices. This comprehensive profile helps physicians detect a wide range of conditions, such as anemia, active infections, inflammation, clotting disorders, and nutritional deficiencies. By providing a detailed snapshot of cellular health, the CBC Complete Hemogram serves as a routine screening tool and a vital step in monitoring existing medical conditions.

The Cardiolipin Antibody (ACL) - IgM Test is a diagnostic blood test used to detect and measure the levels of IgM class antibodies directed against cardiolipin, a crucial phospholipid found in cell membranes. This test is a key component in the evaluation of Antiphospholipid Syndrome (APS), an autoimmune disorder associated with an increased risk of blood clots (thrombosis) in arteries and veins, as well as pregnancy complications like recurrent miscarriages. While IgG antibodies are more commonly associated with APS, testing for IgM provides additional diagnostic sensitivity, especially in acute phases of the condition. The result helps clinicians assess a patient’s risk profile.

The Cardiolipin Antibody (ACL) - IgG Test is a crucial diagnostic blood test used to detect and quantify IgG class antibodies directed against cardiolipin, a key phospholipid found in cell membranes. This test is a primary tool in the diagnosis of Antiphospholipid Syndrome (APS), an autoimmune disorder characterized by unexplained blood clotting (thrombosis) and pregnancy-related complications, such as recurrent miscarriages. Elevated levels of IgG-type ACL antibodies are strongly associated with the risk of these thrombotic events. The test is often ordered alongside IgM and IgA isotypes to provide a comprehensive profile for APS assessment and management.

The Cardiac Risk Marker Test is an advanced diagnostic panel designed to evaluate an individual's long-term likelihood of developing cardiovascular disease or experiencing a heart attack.
Unlike standard lipid profiles, this specialized test measures specific blood biomarkers—such as High-Sensitivity C-Reactive Protein (hs-CRP), Lipoprotein(a), Homocysteine, and Apolipoproteins—which detect hidden inflammation, plaque instability, and genetic predispositions to arterial blockage.
It is especially valuable for individuals with a family history of heart disease, normal cholesterol levels but unexplained cardiac events, or chronic conditions like diabetes. This crucial test enables early, targeted preventive interventions.

The Cardiac Profile - IPD Package is an all-inclusive, in-patient hospital program meticulously designed for individuals requiring intensive cardiac assessment, stabilization, or post-procedure monitoring.
Tailored for patients with acute conditions like unstable angina, recent heart failure exacerbation, or those recovering from interventions such as angioplasty or bypass surgery, this package bundles essential services for a seamless care experience. It typically includes 24/7 nursing care in a cardiac ward, continuous telemetry monitoring, daily consultant visits, comprehensive laboratory work, advanced imaging (like Echocardiograms), and pharmacy support.
By consolidating these critical services, the IPD package ensures coordinated, high-quality care, promotes faster recovery, and provides peace of mind for patients and their families during a hospital stay.

The Cardiac Profile - OPD Package is a comprehensive outpatient health check designed for the early detection, evaluation, and prevention of cardiovascular diseases.
Tailored for individuals with risk factors such as high blood pressure, diabetes, stress, or a family history of heart conditions, this screening bundle typically includes vital diagnostic evaluations like an Electrocardiogram (ECG), Lipid Profile, Fasting Blood Sugar, and a cardiologist consultation.
By assessing key markers of heart health efficiently in a single visit, this package empowers patients to proactively manage their wellness, prevent critical cardiac events, and ensure long-term vitality.

The Cardiac Profile M test is a comprehensive blood package designed to evaluate overall heart health and assess cardiovascular disease risks. Typically consisting of multiple key parameters, this panel combines a complete lipid profile—measuring cholesterol components like HDL, LDL, and triglycerides—with critical cardiac risk markers. By analyzing these specific biochemical indicators, the test helps clinicians identify hidden vulnerabilities, monitor cholesterol management, and detect early signs of potential heart conditions. It serves as a valuable diagnostic tool for preventive health screenings, enabling timely interventions and personalized lifestyle or therapeutic strategies to protect long-term cardiac wellness.

The Cardiac Profile C test is an advanced, comprehensive diagnostic evaluation designed to provide an in-depth analysis of cardiovascular health and intricate heart disease risks. Building upon standard and intermediate screenings, this specialized panel frequently includes high-sensitivity cardiac markers, advanced lipid fractionations, genetic or inflammatory indicators, and specialized coagulation factors. By detecting subtle vascular inflammation, micro-vascular stress, and precise lipoprotein particle sizes, the Cardiac Profile C test offers clinicians granular insight into a patient's long-term wellness. This high-resolution diagnostic tool enables fully personalized preventive strategies, early intervention, and optimized therapeutic management for long-term cardiac protection.

The Cardiac Profile B test is an advanced diagnostic blood panel utilized to comprehensively assess cardiovascular disease risk and evaluate overall heart health. Beyond standard cholesterol measurements, this extensive panel often evaluates specialized biomarkers such as high-sensitivity C-reactive protein (hs-CRP) for inflammation, homocysteine levels, and specific cardiac risk indicators. By identifying hidden arterial inflammation, metabolic imbalances, and early signs of plaque buildup, the Cardiac Profile B test provides physicians with critical data. This empowers patients and healthcare providers to implement targeted preventative interventions, personalize treatment strategies, and effectively lower the long-term risk of heart attacks and strokes.

The Cardiac Profile A test is a comprehensive blood panel designed to evaluate heart health and assess the risk of cardiovascular disease. This screening typically measures key biomarkers such as a lipid profile (including total cholesterol, HDL, LDL, and triglycerides) and fasting blood glucose to detect early warning signs of heart conditions, atherosclerosis, and diabetes-related risks. By providing clear insights into your metabolic and lipid status, this essential diagnostic test empowers you and your healthcare provider to proactively manage heart health, implement lifestyle changes, and prevent future cardiac complications effectively.

C-reactive protein (CRP) is a ring-shaped protein found in the blood plasma, with levels that rise significantly in response to inflammation. Produced primarily by the liver, CRP acts as an important component of the innate immune system, binding to dead or dying cells and foreign pathogens to assist with their clearance. Clinicians frequently order a CRP blood test to detect acute inflammation, screen for infections, and monitor chronic inflammatory conditions like rheumatoid arthritis or inflammatory bowel disease. Elevated CRP levels serve as a non-specific indicator of underlying tissue injury, guiding medical professionals toward accurate diagnoses and effective treatment plans.